Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MetroGel vs Finacea Tolerability in Healthy Skin
NCT01139008Phase 4Completed
- Sponsor
- Galderma
- Start
- Jun 2010
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of metronidazole in rosacea (2 arms), sponsored by Galderma. Primary endpoint: Number of Participants Who Were a Success With Regard to Worst Post-baseline Tolerability Assessment Scores at 3 weeks. Started Jun 2010; status: completed.
02
Drugs
metronidazole
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT01139008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01139008.